Search - tctmd.com

Displaying 181 - 200 of 382

Sort: Relevancy | Date

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Daily News

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

L.A. McKeown

November 17, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Daily News

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

L.A. McKeown

October 09, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Caitlin E. Cox

August 25, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Leah Lawrence

August 01, 2017

News Daily News

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

L.A. McKeown

July 25, 2017

News Industry News

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

July 12, 2017

News Industry News

FDA Grants Market Clearance to Ra Medical Systems for New Peripheral Artery Disease Treatment

June 06, 2017

News Daily News

Readmission for Critical Limb Ischemia Common and Largely Unplanned

L.A. McKeown

April 10, 2017

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

News Industry News

Micro Medical Solutions Receives CE Mark Approval for MicroStent

February 14, 2017

News Industry News

Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

February 13, 2017

News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox

February 10, 2017

Advertisement

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

FDA Grants Market Clearance to Ra Medical Systems for New Peripheral Artery Disease Treatment

Readmission for Critical Limb Ischemia Common and Largely Unplanned

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Micro Medical Solutions Receives CE Mark Approval for MicroStent

Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content